Also, ACE2 receptors have been reported to act as a compensatory mechanism against hyperglycemia induced-RAS activation since hyperglycemia activates ADAM-17 and ACE2 renal shedding that are common in patients with T2DM and IR. This evidence concerns the gene ADAM17 and Hyperglycemia.